Dean Haworth

Dean Haworth brings extensive experience in investment management and corporate finance, currently serving as Director Investment and Head of PM Equity Partner at Philip Morris International. With a focus on North American investments, Dean leads the Corporate Venture Capital arm, managing $350 million in assets. Dean's expertise includes board roles at Azuri Technologies and Biognosys AG, the latter achieving a strategic sale to Bruker Corporation in 2023. Previously, Dean held an investment manager position in a single-family office concentrating on Cleantech investments with $3 billion AUM and worked at PwC Switzerland in financial services. Dean holds a BSc in International Management from the University of Bath and has enhanced credentials with executive education in Private Equity and Venture Capital from Università Bocconi.